Alvaro
Lassaletta Atienza
Consultor Médico
Publicaciones (159) Publicaciones de Alvaro Lassaletta Atienza
2024
-
Artificial intelligence chatbots: Are they a reliable source for patients and families in pediatric neuro-oncology?
Pediatric Blood and Cancer
-
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682
-
Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature
Frontiers in Oncology, Vol. 14
-
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer
Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2351-2359
-
Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma
Frontiers in Oncology, Vol. 14
-
Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 786-795
-
Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience
EJC Paediatric Oncology, Vol. 4
-
Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience
Frontiers in Pediatrics, Vol. 12
2023
-
Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross-sectional nationwide study in Spain
Cancer Reports, Vol. 6, Núm. 2
-
Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine
The Lancet Oncology
-
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 6, pp. 334-341
-
Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
Frontiers in Pediatrics, Vol. 11
-
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution
Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1268-1276
-
Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis
World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740
-
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
Neuro-Oncology, Vol. 25, Núm. 8, pp. 1530-1545
-
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation Sparing Approaches: An International Cohort Study
Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1921-1932
-
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma
Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183
-
Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?
Frontiers in Oncology
-
Role of urine culture in paediatric patients with cancer with fever and neutropenia: A prospective observational study
Archives of Disease in Childhood, Vol. 108, Núm. 12, pp. 982-986
-
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695